Open Access Mandates

A growing number of funding agencies now require that research articles they have funded must be made open access. This may be either by mandating deposit in repositories after an embargo period or by stipulating that research is published as open access.

Publishing in JPD complies with all major funding agency requirements.

From 2023 JPD is an Open Access Journal

IMPORTANT NOTE: From 2023 onwards JPD will be an open access journal, allowing authors the choice of two copyright licences: CC-BY-NC and CC-BY, thereby complying with all major funding mandates (you can read more about the copyright licenses here: https://creativecommons.org/about/cclicenses/). All papers published from 2023 onwards will be published open access. The pre-2023 volume will remain as it is (part paywall, part open access)

.

Gold Open Access Publishing in JPD

Gold open access helps authors to comply with major funder mandates. Gold open access makes the article publicly available in the journal’s contents immediately upon publication. The publisher will also deposit the final, published version of the open access article into PubMed Central upon final publication. All open access articles are published under the terms of the Creative Commons Attribution Non-Commercial License.

The author will have the option to select the Creative Commons Attribution License (CC BY) copyright license for a surcharge. This license is required by certain funding agencies such as the Research Councils UK (RCUK) and Wellcome Trust.

Green Open Access Publishing in JPD for articles published pre-2023 (Self-Archiving)

Authors who's papers were published in the pre-2023 volume, who did not select open access publication, may self-archive and post the final manuscript version on their own institution, company or funding agency repositories immediately upon acceptance. Authors that are funded by the NIH, Research Councils UK (RCUK) and Wellcome Trust are welcome to deposit their final manuscript version to PubMed Central (Submission Method C) and Europe PubMed Central immediately upon acceptance. In all cases a publication reference and URL to the journal’s website must be provided on the first page of the manuscript.

Alternatively, the author can submit the final published PDF version of the article, which can be ordered from IOS Press. This service costs €100/US$120 and an order form will be sent with the galley proof of the article to the corresponding author. Ordered PDFs will be sent to the author after final publication of the article in an issue. IOS Press holds to no embargo period after final publication. Orders for a PDF of published articles can also be sent to order@iospress.nl.

Pre-Prints

JPD has no issue with authors submitting their article to a pre-print service such as BioRxiv or MedRxiv before acceptance in the journal. When submitting, do add a note clarifying that your article is available as a pre-print or in process of becoming a pre-print.